Clever Culture Systems (CC5) Investor update summary

Commercial reach and strategy

• PSC Biotech appointed sole sales agent for APAS® Independence in pharmaceutical manufacturing across the US, Canada and Singapore, expanding access to regional and mid-tier manufacturers.

• The channel complements direct Land & Expand sales to global pharmaceutical accounts; PSC Biotech refers qualified leads, while pricing and sales closure remain under direct control.

• PSC Biotech’s network of more than 1,000 customers and 500+ employees is expected to expand qualified opportunities; instrument-sales uplift is expected from FY28 onward.

• APAS® Independence is deployed or under evaluation at eight of the world’s largest pharmaceutical companies.

Agreement terms and economics

• Agreement executed 13 October 2026 for an initial 36 months, with a 24-month extension option by mutual agreement.

• PSC Biotech earns commissions on hardware sales from accepted, referred opportunities; payment is due 30 days after customer payment, with ongoing software and service revenues excluded.

• PSC Biotech must raise a purchase order for one instrument within 90 days; either party may terminate on three months’ written notice, with commissions applying to qualifying sales completed within nine months after termination or expiry.

Market and product case

• PSC Biotech cited a $500bn U.S. onshoring market for essential medicines and key starting materials; sterile capacity adds environmental-monitoring and plate-reading requirements.

• APAS automates manual environmental-monitoring plate reading, addressing labor intensity, subjectivity and recurring data-integrity findings while freeing microbiology staff for higher-value work.

• APAS is media-agnostic, offering a cost advantage over some competing solutions that use expensive proprietary media.

• APAS is the only U.S. FDA-cleared AI technology for automated cell-culture plate reading.

• Plate volumes generally rise with facility size and activity; monitoring requirements increase with cleanroom classification and risk, with Grade A highest and Grade D or non-classified lowest.